Andlauer Healthcare Group Inc. (TSX:AND)

Andlauer Healthcare Group Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,152	1,656	1,703	1,982	2,244	1,539
Market Cap Growth	35.10%	-2.73%	-14.08%	-11.67%	45.76%	104.19%
Enterprise Value	2,271	1,779	1,764	2,099	2,423	1,615
Last Close Price	54.97	41.88	40.25	46.14	52.36	39.49

Price Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
PE Ratio	32.28	25.69	25.75	25.98	24.94	40.82
Forward PE	31.77	24.48	24.11	28.96	39.95	39.11
PS Ratio	3.31	2.55	2.63	3.06	5.10	4.90
PB Ratio	4.89	3.84	3.63	4.49	6.37	16.32
P/TBV Ratio	17.04	17.00	12.65	23.80	132.62	25.72
P/FCF Ratio	20.96	15.50	21.05	17.79	29.50	33.44
P/OCF Ratio	17.60	13.32	16.31	14.45	26.68	30.18
PEG Ratio	-	11.16	11.16	11.16	11.16	11.16

EV Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
EV/Sales Ratio	3.49	2.74	2.72	3.24	5.51	5.14
EV/EBITDA Ratio	15.68	13.54	13.19	14.41	26.81	30.13
EV/EBIT Ratio	24.74	18.94	18.36	18.97	32.61	33.21
EV/FCF Ratio	22.12	16.65	21.81	18.85	31.86	35.09

Financial Efficiency

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Debt / Equity Ratio	0.41	0.42	0.27	0.37	0.53	1.37
Debt / EBITDA Ratio	1.24	1.11	0.78	0.93	1.61	1.70
Debt / FCF Ratio	1.74	1.70	1.58	1.47	2.46	2.82
Asset Turnover	0.97	0.94	0.93	0.96	0.98	1.35
Inventory Turnover	73.96	60.62	99.90	150.30	161.76	181.93
Quick Ratio	1.25	1.45	2.35	1.92	1.27	1.84
Current Ratio	1.35	1.59	2.52	2.01	1.35	1.92
Return on Equity (ROE)	16.00%	14.31%	14.53%	19.23%	40.30%	48.40%
Return on Assets (ROA)	8.45%	8.52%	8.61%	10.20%	10.36%	13.05%
Return on Invested Capital (ROIC)	9.55%	9.71%	9.99%	12.10%	12.17%	15.10%
Return on Capital Employed (ROCE)	16.10%	15.90%	15.70%	17.70%	13.40%	23.80%

Yields

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Earnings Yield	3.14%	3.89%	3.88%	3.85%	4.01%	2.45%
FCF Yield	4.77%	6.45%	4.75%	5.62%	3.39%	2.99%
Dividend Yield	0.87%	1.00%	0.84%	0.56%	0.38%	0.51%
Payout Ratio	27.60%	25.94%	21.47%	14.27%	8.73%	21.02%
Buyback Yield / Dilution	5.50%	3.90%	0.30%	-6.70%	-3.94%	-1.87%
Total Shareholder Return	6.38%	4.90%	1.15%	-6.13%	-3.56%	-1.37%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2025

Data Sources Report a data error